Mathai Mammen

Mathai Mammen

Amministratore Delegato presso PARABILIS MEDICINES, INC.

Patrimonio netto: 511 971 $ in data 31/05/2026

59 anni
Health Technology
Finance
Consumer Services

Profilo

Mathai Mammen was the founder of Innoviva, Inc., founded in 1996, where the title held was Senior VP-Research & Early Clinical Development from 2011 to 2014.
Dr. Mammen was the founder of Theravance Biopharma, Inc., founded in 1997, where the title held was Senior Vice President-Research & Development from 2014 to 2016.
Current jobs include Chairman, President & Chief Executive Officer at Parabilis Medicines, Inc. since 2023; Director at Kelonia Therapeutics, Inc.; Director at MIT Jameel Clinic; Independent Director at Sandoz Group AG since 2024; Advisor at Foresite Capital Management LLC since 2019; and Senior Advisor at General Atlantic LLC.
Former jobs include Independent Director at 10X Genomics, Inc. from 2017 to 2024; Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2016 to 2017; Global Head-Research & Development at Janssen Research & Development LLC from 2017 to 2022; EVP-Pharmaceuticals, Research & Development at Johnson & Johnson in 2022; Vice President at American Society for Microbiology; and Senior Vice President at Merck & Co., Inc. from 2016 to 2017.
Education includes doctorate degrees from Harvard Medical School, Massachusetts Institute of Technology, and Harvard University, and an undergraduate degree from Dalhousie University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
31/12/2025 6.098 ( 0% ) 511 971 $ 31/05/2026
10/06/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Mathai Mammen

SocietàPosizioneInizio
PARABILIS MEDICINES, INC. Amministratore Delegato 30/06/2023
SANDOZ GROUP AG Direttore/Membro del Consiglio 30/04/2024
Consulente / Consigliere -
Consulente / Consigliere 01/01/2019
MIT Jameel Clinic
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Mathai Mammen

SocietàPosizioneFine
10X GENOMICS, INC. Direttore/Membro del Consiglio 24/10/2024
JOHNSON & JOHNSON Direttore Tecnico/Scientifico/R&S 08/08/2022
Corporate Officer/Principal 01/01/2022
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Mathai Mammen

Formazione di Mathai Mammen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

47

Relazioni di 1° grado

18

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private18

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Consumer Services

Finance

Commercial Services

Health Technology

Health Technology

MIT Jameel Clinic

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Mathai Mammen
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA